Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

TAX 2

Next Previous
X
Search
Drug Profile

TAX 2

Alternative Names: AP-01 - Apmonia Therapeutics; AP-02 - Apmonia Therapeutics; TAX-2

Latest Information Update: 21 Jul 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator CNRS; University of Reims
  • Developer Apmonia Therapeutics
  • Class Antineoplastics; Antithrombotics; Cyclic peptides
  • Mechanism of Action Immunostimulants; Interferon gamma stimulants; Platelet aggregation inhibitors; Thrombospondin antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Thrombosis

Highest Development Phases

  • Preclinical Thrombosis
  • No development reported Solid tumours

Most Recent Events

  • 31 May 2024 Pharmacodynamics and pharmacokinetics data from a preclinical study in Solide tumours presented at the 60th Annual Meeting of the American Society of Clinical Oncology (ASCO-2024)
  • 31 May 2024 Apmonia Therapeutics plans a first in human trial for Solid tumours
  • 28 Mar 2023 No recent reports of development identified for preclinical development in Solid-tumours in France (Intraperitoneal, Injection)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top